Daniel Sharp
Direktor/Vorstandsmitglied bei ALCIDION GROUP LIMITED
Vermögen: 488 743 $ am 30.04.2024
Profil
Daniel Sharp is currently a Non-Executive Director at Botanix Pharmaceuticals Ltd.
and an Independent Non-Executive Director at Alcidion Group Ltd.
He previously served as an Independent Non-Executive Director at ImpediMed Ltd.
in 2023, an Executive Director at Shaw & Partners Corporate Finance Pty Ltd., and an Executive Director at Canaccord Genuity (Australia) Ltd.
from 2012 to 2020.
He also served as an Independent Non-Executive Director at Race Oncology Ltd.
in 2022-2023.
Mr. Sharp received his undergraduate and graduate degrees from Monash University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
IMPEDIMED LIMITED
0,41% | 28.09.2023 | 8 234 192 ( 0,41% ) | 449 175 $ | 30.04.2024 |
ALCIDION GROUP LIMITED
0,08% | 30.06.2023 | 1 128 572 ( 0,08% ) | 39 568 $ | 30.04.2024 |
Aktive Positionen von Daniel Sharp
Unternehmen | Position | Beginn |
---|---|---|
ALCIDION GROUP LIMITED | Direktor/Vorstandsmitglied | 01.09.2021 |
BOTANIX PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 22.03.2022 |
Ehemalige bekannte Positionen von Daniel Sharp
Unternehmen | Position | Ende |
---|---|---|
IMPEDIMED LIMITED | Direktor/Vorstandsmitglied | 28.09.2023 |
RACE ONCOLOGY LIMITED | Direktor/Vorstandsmitglied | 29.06.2023 |
Canaccord Genuity (Australia) Ltd.
Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Canaccord Genuity (Australia) Ltd. (Canaccord Genuity Australia) is the Australian full service stockbroking and wealth management subsidiary of Canaccord Genuity Group Inc. (TSE: CF) in Canada. Headquartered in Melbourne, Canaccord Genuity Australia was founded by Anthony Murphy and provides wealth management services including portfolio management, portfolio administration and broking services to individual, institutional and corporate clients. | Direktor/Vorstandsmitglied | 01.01.2020 |
Shaw & Partners Corporate Finance Pty Ltd.
Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Part of EFG International AG, Shaw & Partners Corporate Finance Pty Ltd. is a brokerage firm founded in 1987. The private company is based in Sydney, Australia and provides brokerage services. | Corporate Officer/Principal | - |
Ausbildung von Daniel Sharp
Monash University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ALCIDION GROUP LIMITED | Technology Services |
BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
RACE ONCOLOGY LIMITED | Health Technology |
IMPEDIMED LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
Shaw & Partners Corporate Finance Pty Ltd.
Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Part of EFG International AG, Shaw & Partners Corporate Finance Pty Ltd. is a brokerage firm founded in 1987. The private company is based in Sydney, Australia and provides brokerage services. | Finance |
Canaccord Genuity (Australia) Ltd.
Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Canaccord Genuity (Australia) Ltd. (Canaccord Genuity Australia) is the Australian full service stockbroking and wealth management subsidiary of Canaccord Genuity Group Inc. (TSE: CF) in Canada. Headquartered in Melbourne, Canaccord Genuity Australia was founded by Anthony Murphy and provides wealth management services including portfolio management, portfolio administration and broking services to individual, institutional and corporate clients. | Finance |